Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System ...Middle East

Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. PORTAGE, Mich., May 19, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced that its OptaBlate...

Read More Details
Finally We wish PressBee provided you with enough information of ( Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System )

Also on site :

• A look at six bills in Albany awaiting Gov. Hochul’s signature
• This 'Iconic' Cereal is Finally Making a Comeback and Fans Going Wild: 'Holy Smokes'
• Canadian mining giant loses operational control in African state